Log
Sign in, then log shots, side effects, and weight in a few taps.
For Ozempic · Wegovy · Mounjaro · Zepbound · compounded GLP-1s
See what your GLP-1 logs are saying.
Dosey turns your shots, side effects, and weight into a weekly readout, shown against SURMOUNT-1 trial context and Dosey cohort references as the dataset grows.
Why Dosey exists
You log. You weigh in. You wonder what it means.
Six weeks in, the scale moves, then it doesn't, then a symptom changes and you wonder if it's the dose or the day or just bad sleep. Most trackers hand you a chart and leave the interpretation to you - or worse, a dashboard with eight panels and no answer.
Dosey reads your logs against published GLP-1 trial data and growing cohort context, then writes a one-paragraph weekly readout. The chart is the evidence. The readout is the answer. You bring it to your next clinic visit so the conversation starts with data, not memory.
How it works
Three steps to your readout.
Readout
Each week, Dosey reads your logs against published trial context and, as the cohort grows, aggregated Dosey usage to write one plain-language readout.
Discuss
Bring the readout, or a compiled doctor-ready PDF, to your next clinic visit so the conversation starts with data, not memory.
Free to start. Pro will unlock deeper patterns, plateau signals, side-effect timing, and the compiled doctor-ready PDF.
What a readout looks like
Sample readouts.
Three example readings showing the tone Dosey uses. Yours is generated from your own logs, with cohort-derived personalization added only when the aggregate read model exists.
Moving steadily
At week 9 your weight trend is moving below baseline and your shot timing has stayed consistent. Side effects are clustering near the day after your shot.
Discussion pointAsk which patterns your clinician wants you to keep tracking before the next visit.
Example readout based on sample data
Plateau signal
Weight has stayed within a narrow range for three weeks. Your shot cadence is still visible, but the progress curve has flattened enough to become a discussion point.
Discussion pointBring up recent meals, movement, side-effect timing, and whether your clinician wants any other measurements tracked.
Example readout based on sample data
Reference contextPro
Your entries show a slower change than the reference lines shown in Dosey. That does not prove why; it gives you a clean pattern to discuss.
Discussion pointAsk what context matters most: dose history, adherence, side effects, nutrition, or preparation details.
Example readout based on sample data
Data you control
Your data should work for you.
Dosey can use the information you choose to save to create clearer readouts, pattern insights, analytics, and clinic-ready summaries. The line is simple: use data to serve the person who entered it, not to sell it to advertisers, brokers, or third-party health marketing networks.
Data used for your readouts and reportsNo selling health data or ad targetingClear export and deletion controls
Who it's for
If you're on a GLP-1, this is for you.
Whether you're in week one of titration or year two of maintenance:
- Semaglutide (Ozempic, Wegovy, Rybelsus)
- Tirzepatide (Mounjaro, Zepbound)
- Liraglutide (Saxenda, Victoza)
- Compounded semaglutide or tirzepatide preparations
Dosey speaks GLP-1 - shots, sites, titration weeks, plateau stretches - so you don't have to translate from a generic weight app.
The fine print, upfront
What Dosey isn't.
Dosey is a personal tracking tool with a readout on top. It is not:
- A medical device or a substitute for your clinician's guidance
- A way to change your dose - always talk to your clinician about dose decisions
- A diagnostic tool - Dosey shows personal patterns and reference context, not predictions
If you have an urgent medical concern, contact your clinician or local emergency services.
Join early access
Be first to your weekly readout.
One email when Dosey is ready. No drip campaign, no resold list.
FAQ
Common questions
What is a weekly readout?
A one-paragraph reading of your logs each week, shown against published GLP-1 trial context and reference lines. It describes patterns and discussion points for your clinician, not a diagnosis or a dose recommendation.
Is Dosey live?
Yes. The public website and sample report are live today. Sign in with Google to open the tracker, log a shot and a progress entry, and preview a doctor-ready summary.
Is Dosey free?
Tracking your shots, side effects, weight, and progress is free, and the weekly readout is free. Pro will add deeper pattern context, plateau signals, side-effect timing, and the compiled doctor-ready PDF after beta feedback.
Do I need to sign up to use the tracker?
Yes. The tracker sits behind Google sign-in so Dosey can save logs to your account for analytics, saved reports, and cross-browser access. Public landing, privacy, and sample-report pages stay available without signing in.
Is the readout medical advice?
No. The readout describes patterns - it doesn't diagnose, recommend dose changes, or replace medical guidance. Wording is intentionally observational ("pattern", "trend", "discussion point") so you can bring it into a conversation with your clinician.
Where do the trial and cohort comparisons come from?
Trial averages come from published GLP-1 clinical trials (e.g. SURMOUNT-1 for tirzepatide). Real-world cohort comparisons come from aggregated Dosey usage as the cohort grows, with clear labelling and without claiming live personalization before the aggregate read model exists.
What devices does Dosey work on?
Dosey runs in any modern browser on desktop, laptop, tablet, and phone. A dedicated mobile app is on hold while we focus the web product. Add Dosey to your phone's home screen for a faster-loading shortcut in the meantime.
Will Dosey sell or share my data?
Dosey uses your data to serve you: better readouts, clearer patterns, account features, support, and product quality. We will not sell health data, work with data brokers, or use medication logs for ad targeting.